A Programmable Prompting Device Improves Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Subjects with Memory Impairment
Open Access
- 15 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 875-882
- https://doi.org/10.1086/432877
Abstract
Background. Patients cite “forgetting” as a reason for nonadherence to highly active antiretroviral therapy (HAART). We measured the effect of a memory-prompting device on adherence to HAART in memory-intact and memory-impaired human immunodeficiency virus (HIV)—infected subjects. Methods. The study was a prospective, randomized, controlled trial involving 64 HIV-infected adults. The intervention was the Disease Management Assistance System (DMAS) device, combined with monthly adherence counseling. Control subjects received only adherence counseling. The DMAS was programmed with HAART regimen data to provide verbal reminders at dosing times. Adherence was measured for 24 weeks using electronic drug exposure monitor (eDEM) caps. Results. A total of 58 subjects completed the 24-week study period; 28 were HAART naive (12 DMAS users and 16 control subjects). Mean adherence scores did not differ significantly between DMAS users (80%) and control subjects (65%). Post hoc analysis of 31 memory-impaired subjects (14 DMAS users and 17 control subjects) revealed significantly higher adherence rates among DMAS users (77%), compared with control subjects (57%) (P = .001). However, analysis of memory-intact subjects showed that adherence was not significantly improved for DMAS users (83%), compared with control subjects (77%) (P = .25). At week twelve, 38% of the DMAS users and 14% of the control subjects had an undetectable plasma HIV RNA load (P = .014), and at week 24, the plasma HIV RNA load was undetectable for 34% of the DMAS users and 38% of the control subjects (P = .49). CD4+ cell counts did not differ between the study arms. Virological and immunological responses were not related to DMAS use in memory-impaired subjects. Conclusion. The DMAS prompting device improved adherence for memory-impaired subjects but not for memory-intact subjects.Keywords
This publication has 25 references indexed in Scilit:
- Medication Management Skill in HIV: I. Evidence for Adaptation of Medication Management Strategies in People with Cognitive Impairment. II. Evidence for a Pervasive Lay Model of Medication EfficacyAIDS and Behavior, 2003
- Medication adherence among HIV+ adultsNeurology, 2002
- Measurement of Adherence to Antiretroviral MedicationsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Neurocognitive Aspects of Medication Adherence in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Adherence to Antiretroviral Therapy: Where Are We, and Where Do We Go From Here?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence InstrumentsAIDS Care, 2000
- Evaluation of an electronic memory aid in the neuropsychological rehabilitation of prospective memory deficitsBrain Injury, 2000
- Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapyCurrent Infectious Disease Reports, 1999
- Human immunodeficiency virus (HIV) infection and the nervous systemNeurology, 1989
- An analysis of variance test for normality (complete samples)Biometrika, 1965